CeriBell, Inc.

Stage 2 · Advancing · week 10

As of Oct 22, 2026, CeriBell is in Stage 2, the uptrend phase, now in week 10 (since Aug 13, 2026). It closed at $27.40, 1.0% below its 52-week high and above its 200-day average, which is rising.

CeriBell, Inc. operates as a medical technology company in the United States. More about the company

$27.40

+0.96% today

$1.1B · Small cap

Market Neutral — Fading

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care

Is CBLL early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-10-11 → 2026-10-22

S? 42w

S4 15w

S2 10w

S3 9w

S2 10w

2024-10-112026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 15w → S1 6w → S2 10w → S3 8w → S2 4w → S3 9w → S4 1w → S2 10w current

Total tracked: 106 weeks across 9 stage runs.

CBLL among Medical Devices9th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
9	CBLLCeriBell, Inc.	Stage 2 · wk 10	95	+16.0%

vs 52W High

-1.0%

$10.92 lo$27.68 hi

Near 52W high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 10

1w13w26w

Week 10, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

32.7%

200 DMA: $20.66 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.93x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↑

Short-term trend rising strongly

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+16.0%

+62.0%

+30.1%

YTD

+28.6%

+104.8%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S2

Wk 10 · Vol 0.93x

2026-10-21S2

Wk 10 · Vol 1.03x

2026-10-20S2

Wk 10 · Vol 1.41x

2026-10-19S2

Wk 10 · Vol 1.54x

2026-10-16S2

Wk 10 · Vol 1.00x

2026-10-15S2

Wk 9 · Vol 2.32x

2026-10-14S2

Wk 9 · Vol 2.32x

2026-10-13S2

Wk 9 · Vol 1.42x

2026-10-12S2

Wk 9 · Vol 1.85x

2026-10-09S2

Wk 9 · Vol 0.86x

2026-10-08S2

Wk 8 · Vol 0.65x

2026-10-07S2

Wk 8 · Vol 0.81x

Moving averages & range

50 DMA

$24.55

200 DMA

$20.66

52W High

$27.68

52W Low

$10.92

5D Low

$25.04

Resistance levels (recent highs)

20d High

$27.68

60d High

$27.68

120d High

$27.68

250d High

$27.68

Next resistance

+1.0%

to 20d High

ROE

-43.9%

Profit margin -64.7%

Dividend Yield

0.00%

P/B 8.2

CeriBell: quick answers

What stage is CeriBell in?

As of Oct 22, 2026, CeriBell (CBLL) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 13, 2026 and is in week 10. What the four stages mean

Is CeriBell in an uptrend?

Yes. CeriBell is in a Stage 2 uptrend. It trades 32.7% above its 200-day average, which is rising.

How far is CeriBell from its 52-week high?

CeriBell closed at $27.40 on Oct 22, 2026, 1.0% below its 52-week high of $27.68. Its 52-week low is $10.92.

How has CeriBell performed over the past year?

As of Oct 22, 2026, CeriBell is up 104.8% over the past year and up 28.6% so far in 2026.

Which sector and industry is CeriBell in?

CeriBell is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.